1 March 2023 false Taxfiler 2024.6 13901952business:PrivateLimitedCompanyLtd2023-03-012024-02-29 139019522023-02-28 139019522023-03-012024-02-29 13901952business:AuditExemptWithAccountantsReport2023-03-012024-02-29 13901952business:AbridgedAccounts2023-03-012024-02-29 139019522024-02-29 13901952business:Director12023-03-012024-02-29 13901952business:RegisteredOffice2023-03-012024-02-29 139019522023-02-28 13901952core:WithinOneYear2024-02-29 13901952core:WithinOneYear2023-02-28 13901952core:ShareCapitalcore:PreviouslyStatedAmount2024-02-29 13901952core:ShareCapitalcore:PreviouslyStatedAmount2023-02-28 13901952core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-02-29 13901952core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-02-28 13901952core:PreviouslyStatedAmount2024-02-29 13901952core:PreviouslyStatedAmount2023-02-28 13901952business:SmallEntities2023-03-012024-02-29 13901952countries:EnglandWales2023-03-012024-02-29 13901952core:ComputerEquipment2023-03-012024-02-29 13901952core:AcceleratedTaxDepreciationDeferredTax2024-02-29 13901952core:AcceleratedTaxDepreciationDeferredTax2023-02-28 139019522022-02-07 139019522022-02-082023-02-28 13901952business:OrdinaryShareClass12023-03-012024-02-29 13901952business:OrdinaryShareClass12022-02-082023-02-28 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 13901952 (England and Wales)
ZA Pharm Ltd Unaudited accounts for the year ended 29 February 2024
ZA Pharm Ltd Unaudited accounts Contents
Page
- 2 -
ZA Pharm Ltd Company Information for the year ended 29 February 2024
Director
Miss Zeenat Ali
Company Number
13901952 (England and Wales)
Registered Office
130 Laund Road Salendine Nook Huddersfield West Yorkshire HD3 3TY United Kingdom
Accountants
Pinnacle Chartered Accountants & Tax Advisors The Elsie Whiteley Innovation Centre Hopwood Lane Halifax HX1 5ER
- 3 -
ZA Pharm Ltd Statement of financial position as at 29 February 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
1,324 
300 
Current assets
Debtors
64 
221 
Cash at bank and in hand
5,352 
10,067 
5,416 
10,288 
Creditors: amounts falling due within one year
(6,388)
(4,278)
Net current (liabilities)/assets
(972)
6,010 
Total assets less current liabilities
352 
6,310 
Provisions for liabilities
Deferred tax
(252)
(57)
Net assets
100 
6,253 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
- 
6,153 
Shareholders' funds
100 
6,253 
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 28 November 2024 and were signed on its behalf by
Miss Zeenat Ali Director Company Registration No. 13901952
- 4 -
ZA Pharm Ltd Notes to the Accounts for the year ended 29 February 2024
1
Statutory information
ZA Pharm Ltd is a private company, limited by shares, registered in England and Wales, registration number 13901952. The registered office is 130 Laund Road, Salendine Nook, Huddersfield, West Yorkshire, HD3 3TY, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts and rebates. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% on cost
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
- 5 -
ZA Pharm Ltd Notes to the Accounts for the year ended 29 February 2024
4
Tangible fixed assets
Total 
£ 
Cost or valuation
At 1 March 2023
400 
Additions
1,499 
At 29 February 2024
1,899 
Depreciation
At 1 March 2023
100 
Charge for the year
475 
At 29 February 2024
575 
Net book value
At 29 February 2024
1,324 
At 28 February 2023
300 
5
Deferred taxation
2024 
2023 
£ 
£ 
Accelerated capital allowances
252 
57 
2024 
2023 
£ 
£ 
Provision at start of year
57 
- 
Charged to the profit and loss account
195 
57 
Provision at end of year
252 
57 
6
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
10 Ordinary shares of £10 each
100 
100 
7
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -